(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

OVA1

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

OVA1

ST13

US500000085975100

Class

1, 5, 42, 44

Filing

85975100

Registration

3946352

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

45

Latest update

10/29/2021

Trademark type

Combined

Nice classes

1, 5, 42, 44

Filing date

04/01/2010

Registration date

04/12/2011

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

10/29/2021

Last transaction

10/29/2021

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

03/09/2010

First use in commerce

03/09/2010

Drawing code

3

Owner type

03

Owner location

AUSTIN, TX

Examiner

OKEKE, BENJAMIN

Law office

M30

Current location

GENERIC WEB UPDATE

Mark description

The mark consists of the term "OVA" written in a stylized script in teal followed by the number "1" in superscript in white inside an orange circle.

Holders and representatives

Holders

ASPIRA WOMEN'S HEALTH INC.
Vermillion, Inc.
Vermillion, Inc.

Representatives

Melissa Hunter-Ensor Greenberg Traurig, LLP

Technical classification

Nice Classes

Class 1Class 5Class 42Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Reagents for scientific or medical research use

Class 5

Reagentsdiagnostic preparations for medical purposes; diagnostic kits consisting primarily of monoclonal antibodiesbuffers and reagents for use in disease testing

Class 42

Providing medical and scientific research in the field of pharmaceutical and clinical trials; medical and scientific research services in the field of cancer treatment and diagnosis; providing reagent sample testing and diagnostic services for others in the fields of science and research related thereto; product development services for others in the biomedicalgenomicspharmacogenomicsdiagnosticclinical trial design and biotechnology fields

Class 44

Providing medical information; medical consulting in the field of biological infection disease control

Publications

History of USPTO decisions and trademark events.

45 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

10/29/2021

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

10/29/2021

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

10/29/2021

EROP

TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED

10/28/2021

PR89

POST REGISTRATION ACTION MAILED - SEC. 8 & 9

07/07/2021

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

07/07/2021

E89R

TEAS SECTION 8 & 9 RECEIVED

03/30/2021

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

08/12/2020

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

04/12/2020

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

11/13/2017

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

11/13/2017

EROP

TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED

11/13/2017

PR23

POST REGISTRATION ACTION MAILED - SEC. 8 & 15

05/16/2017

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

05/16/2017

E815

TEAS SECTION 8 & 15 RECEIVED

04/03/2017

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

04/03/2017

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

10/17/2016

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

10/17/2016

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

04/12/2016

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

06/29/2015

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

06/29/2015

R.PR

REGISTERED-PRINCIPAL REGISTER

04/12/2011

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

03/08/2011

REGV

LAW OFFICE REGISTRATION REVIEW COMPLETED

03/07/2011

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

03/07/2011

MDSM

NOTICE OF DESIGN SEARCH CODE MAILED

03/05/2011

SUPC

STATEMENT OF USE PROCESSING COMPLETE

03/04/2011

DPCC

DIVISIONAL PROCESSING COMPLETE

03/04/2011

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

03/03/2011

IUAF

USE AMENDMENT FILED

02/15/2011

DRRR

DIVISIONAL REQUEST RECEIVED

02/15/2011

ERTD

TEAS REQUEST TO DIVIDE RECEIVED

02/15/2011

EISU

TEAS STATEMENT OF USE RECEIVED

02/15/2011

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

08/17/2010

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

08/12/2010

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

08/12/2010

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

06/22/2010

PUBO

PUBLISHED FOR OPPOSITION

06/22/2010

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

05/18/2010

ALIE

ASSIGNED TO LIE

05/18/2010

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

05/08/2010

DOCK

ASSIGNED TO EXAMINER

04/28/2010

MDSM

NOTICE OF DESIGN SEARCH CODE MAILED

04/07/2010

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

04/06/2010

NWAP

NEW APPLICATION ENTERED

04/05/2010

Continuous trademark protection

Get notified about every new filing that threatens OVA1 or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.